Back | Next |
home / stock / insm / insm message board
Subject | By | Source | When |
---|---|---|---|
Blueyedcatch, Are you still around? Yesterday was a great day | FTR | investorshub | 08/08/2018 8:28:48 AM |
Very exciting times for Insmed. Great data,,major expansion | blueyedcatch | investorshub | 11/03/2017 8:52:45 PM |
Chart that | oxnous | investorshub | 10/18/2017 5:07:30 PM |
Thanks for the encouragement. I will wait for | oxnous | investorshub | 10/13/2017 7:41:48 PM |
Oxnous, I just think you're in time. Take you're time | FTR | investorshub | 10/02/2017 8:21:15 AM |
LooKS like I missed this one. GLTA | oxnous | investorshub | 09/30/2017 5:03:13 AM |
Ahh yes,,but Gottlieb is transforming the FDA to | blueyedcatch | investorshub | 09/27/2017 7:29:24 PM |
I will continue to monitor for news. I | oxnous | investorshub | 09/27/2017 6:57:23 PM |
Iplex is free and clear for Insm from | blueyedcatch | investorshub | 09/17/2017 4:51:03 PM |
Been a long time. Was the drug involved | north40000 | investorshub | 09/15/2017 3:14:07 PM |
Smart man. | Reluctant Observer | investorshub | 09/15/2017 3:00:18 PM |
In since DNA patent battle that was settled....sold | north40000 | investorshub | 09/15/2017 2:59:25 PM |
PGA$. Worked good today for me :). | Crazyjake27 | investorshub | 09/13/2017 8:35:24 PM |
Knew this was pumped and would head down | John Kent | investorshub | 09/13/2017 8:33:11 PM |
Thank you JK. | Crazyjake27 | investorshub | 09/13/2017 7:35:08 PM |
Blueyedcatch, Sorry I don't have an account to post.. Just lurking... | FTR | investorshub | 09/13/2017 7:14:05 PM |
Can you do us a favor and post | blueyedcatch | investorshub | 09/13/2017 12:07:59 PM |
Reluctant, Welcome back... I'm still here since 2001... The other oldies | FTR | investorshub | 09/13/2017 10:52:46 AM |
I am. Since 2006 | blueyedcatch | investorshub | 09/13/2017 1:47:14 AM |
Anyone here from the old days? 2008 ish? | Reluctant Observer | investorshub | 09/13/2017 1:00:20 AM |
News, Short Squeeze, Breakout and More Instantly...
2024-07-12 10:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-09 08:00:06 ET Vamil Divan from Guggenheim issued a price target of $95.00 for INSM on 2024-07-09 06:44:00. The adjusted price target was set to $95.00. At the time of the announcement, INSM was trading at $70.05. The overall price target consensus is at $72.91 w...
Additional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis Conference PR Newswire —New Graph Depicting 52-Week FEV1 Data Illustrate Significantly Less Decline in Lung Function for Bren...